[go: up one dir, main page]

ATE331537T1 - Topisch anwendbare arzneimittelformulierung - Google Patents

Topisch anwendbare arzneimittelformulierung

Info

Publication number
ATE331537T1
ATE331537T1 AT02747591T AT02747591T ATE331537T1 AT E331537 T1 ATE331537 T1 AT E331537T1 AT 02747591 T AT02747591 T AT 02747591T AT 02747591 T AT02747591 T AT 02747591T AT E331537 T1 ATE331537 T1 AT E331537T1
Authority
AT
Austria
Prior art keywords
topically applicable
medicinal formulation
applicable medicinal
formulation
topically
Prior art date
Application number
AT02747591T
Other languages
English (en)
Inventor
Alvin Berlat
Original Assignee
Advanced Biotechnologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23190223&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE331537(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Advanced Biotechnologies filed Critical Advanced Biotechnologies
Application granted granted Critical
Publication of ATE331537T1 publication Critical patent/ATE331537T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0066Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104Silver, e.g. silver sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02747591T 2001-07-24 2002-07-23 Topisch anwendbare arzneimittelformulierung ATE331537T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30754801P 2001-07-24 2001-07-24

Publications (1)

Publication Number Publication Date
ATE331537T1 true ATE331537T1 (de) 2006-07-15

Family

ID=23190223

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02747591T ATE331537T1 (de) 2001-07-24 2002-07-23 Topisch anwendbare arzneimittelformulierung

Country Status (20)

Country Link
US (1) US8263114B2 (de)
EP (1) EP1409034B1 (de)
JP (1) JP3778559B2 (de)
KR (1) KR101009267B1 (de)
CN (1) CN1234426C (de)
AT (1) ATE331537T1 (de)
AU (1) AU2002317981B2 (de)
BR (1) BRPI0211282B8 (de)
CA (1) CA2454673C (de)
DE (1) DE60212847T2 (de)
DK (1) DK1409034T3 (de)
ES (1) ES2268061T3 (de)
IL (2) IL160109A0 (de)
MX (1) MXPA04000444A (de)
NO (1) NO334175B1 (de)
NZ (1) NZ529957A (de)
PT (1) PT1409034E (de)
RU (1) RU2306121C2 (de)
WO (1) WO2003009877A1 (de)
ZA (1) ZA200400488B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070237834A1 (en) * 2003-04-18 2007-10-11 Bioderm Research Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis)
JP4818108B2 (ja) * 2003-07-03 2011-11-16 ザ、ユニバーシティー、コート、オブ、ザ、ユニバーシティー、オブ、セント、アンドルーズ 一酸化窒素放出用ゼオライト
KR101528918B1 (ko) * 2004-11-07 2015-06-15 쿠프론 인코포레이티드 상처, 화상 및 다른 피부 질환을 치료하기 위한 구리 함유물질
US20110046532A1 (en) * 2006-01-30 2011-02-24 Sanjeev Kaila composition including a silicone-based polymer and a method of treating skin disorders using the composition
MX2009014009A (es) * 2007-06-29 2010-05-20 Carmanah Technologies Corp Sistema de iluminacion de areas inteligente.
UA28103U (uk) * 2007-07-12 2007-11-26 Ольга Олександрівна Біляєва Комплексний сорбційно-протеолітичний препарат сертасил для лікування гнійних ран, трофічних виразок, опіків
GB0821345D0 (en) * 2008-11-21 2008-12-31 P Q Silicas Uk Ltd Composition and dressing with nitric oxide
WO2010079209A2 (en) * 2009-01-08 2010-07-15 Golub Alexandr A Compositions for treating wounds and skin conditions
US20100322875A1 (en) * 2009-06-18 2010-12-23 Advanced Bio-Technologies, Inc. Silicone scar treatment preparation
AU2010274000A1 (en) * 2009-07-17 2012-02-02 Carefusion 2200, Inc. Particles incorporating antimicrobial agents
RU2429820C2 (ru) * 2009-09-24 2011-09-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" (ЗАО"ИПН") Антисептическая мазь наружного применения (2 варианта)
DK2496263T3 (da) 2009-11-03 2022-03-28 Lipidor Ab Lipidlagsdannende sammensætning til administration på en overflade af en levende organisme
AU2010316006B2 (en) * 2009-11-03 2013-09-26 Lipidor Ab Composition for promoting wound healing
CN103079604B (zh) * 2010-06-17 2017-07-04 科发龙技术公司 抗微生物硅酮系创伤敷料
WO2012150890A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Antibacterial composition
US20130144225A1 (en) 2011-12-06 2013-06-06 Jessica Rowen Method And Device For Scar Management
TWI474823B (zh) * 2013-09-25 2015-03-01 Far Eastern New Century Corp 疤痕凝膠的組成物
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
CN106729963A (zh) * 2016-12-22 2017-05-31 苏州迈达医疗器械有限公司 一种硅酮凝胶敷料及其生产工艺
US10496949B2 (en) 2017-01-04 2019-12-03 Christopher Zoumalan Compositions and methods for treating cutaneous conditions
RU2674445C1 (ru) * 2017-12-11 2018-12-10 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия имени С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Спрей для наружного применения спиртовой
CN108714141A (zh) * 2018-05-29 2018-10-30 南京华开生物科技有限公司 硅酮疤痕喷剂
EP3827051A4 (de) * 2018-07-26 2022-03-02 Exciton Pharma Corp. Fahrzeuge und abgabesysteme für oxidationsmittel
CA3115032A1 (en) * 2018-09-26 2020-04-02 Exaltexx Inc. Winterized maturing agent, viscosity reducer and production enhancer
US11433016B2 (en) 2019-03-28 2022-09-06 L'oreal Cosmetic compositions for skin
US11207255B2 (en) 2019-07-30 2021-12-28 L'oreal Perfluoro-free self-foaming facial cleanser composition
US11364190B2 (en) 2019-07-30 2022-06-21 L'oreal Acid perfluoro-free self-foaming facial cleanser composition
US12109279B2 (en) 2020-08-25 2024-10-08 L'oreal Self-bubbling peel-away cleansing mask
US11213473B1 (en) 2020-09-18 2022-01-04 Christopher Zoumalan Skin brightening composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0618899B2 (ja) * 1987-06-30 1994-03-16 品川燃料株式会社 抗菌性ゼオライト含有フィルム
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
JPH049327A (ja) 1990-04-04 1992-01-14 Kootec Kk 創傷被覆材
DE4034705A1 (de) * 1990-10-31 1992-05-07 Martin Neumann Wundverschluss
FR2678513B1 (fr) * 1991-07-03 1995-06-30 Laboratoires Hygiene Dietetique Pansement cicatrisant.
JPH11509442A (ja) 1995-07-19 1999-08-24 イノベイティブ・テクノロジーズ・リミテッド 創傷処置組成物
US5833998A (en) * 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
JPH09194350A (ja) 1996-01-19 1997-07-29 Morishita Jintan Kk 創傷被覆材
US6231259B1 (en) * 1996-07-26 2001-05-15 The Gillette Company Viscous product dispenser with porous dome
US5741509A (en) * 1996-08-26 1998-04-21 Alvin S. Berlat Silicone wound dressing
AU1923199A (en) * 1997-12-17 1999-07-05 Hemodynamics, Inc. Sealing media for surgery and wound closure
WO2000047183A1 (en) 1999-02-12 2000-08-17 The Procter & Gamble Company Skin sanitizing compositions
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
GB0007140D0 (en) * 1999-09-27 2000-05-17 Dow Corning Sa Scar treatment composition
AU2001256347A1 (en) * 2000-05-23 2001-12-03 Unilever Plc Deodorant and/or antiperspirant compositions
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
GEP20125661B (en) * 2007-09-30 2012-10-10 Meda Ab Silicone gel-based compositions for wound healing and scar removal

Also Published As

Publication number Publication date
ES2268061T3 (es) 2007-03-16
EP1409034B1 (de) 2006-06-28
US20040234474A1 (en) 2004-11-25
BR0211282A (pt) 2004-08-03
CA2454673C (en) 2011-04-26
NO334175B1 (no) 2014-01-06
ZA200400488B (en) 2005-06-29
AU2002317981B2 (en) 2006-12-07
BR0211282B1 (pt) 2018-01-09
RU2306121C2 (ru) 2007-09-20
RU2004105164A (ru) 2005-06-27
KR20040032864A (ko) 2004-04-17
KR101009267B1 (ko) 2011-01-18
CN1234426C (zh) 2006-01-04
IL160109A0 (en) 2004-06-20
DE60212847D1 (de) 2006-08-10
CA2454673A1 (en) 2003-02-06
NZ529957A (en) 2005-11-25
DE60212847T2 (de) 2007-06-14
JP2005502639A (ja) 2005-01-27
PT1409034E (pt) 2006-11-30
NO20040319L (no) 2004-01-23
US8263114B2 (en) 2012-09-11
BRPI0211282B8 (pt) 2021-05-25
IL160109A (en) 2008-04-13
WO2003009877A1 (en) 2003-02-06
DK1409034T3 (da) 2006-10-30
HK1061362A1 (en) 2004-09-17
MXPA04000444A (es) 2004-10-27
CN1527729A (zh) 2004-09-08
EP1409034A1 (de) 2004-04-21
JP3778559B2 (ja) 2006-05-24

Similar Documents

Publication Publication Date Title
DE60212847D1 (de) Topisch anwendbare arzneimittelformulierung
BR0107869A (pt) Composições farmacêuticas eletrogiradas
ID27504A (id) Formulasi oral baru
DE60105448D1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
EE05383B1 (et) Polarlkarboksamiidhendid,ÁnendeÁvalmistamineÁjaÁkasutamineÁlipiiditasetÁalandavateÁtoimeainetenaÁningÁneidÁsisaldavÁfarmatseutilineÁkompositsioon
PL367686A1 (en) Pharmaceutical formulation comprising a proton pump inhibitor and antacids
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
AU2002335046A1 (en) The use of proton sequestering agents in drug formulations
IS7065A (is) Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð
NO20040254L (no) Farmasoytiske sammensetninger som inneholder terbinafin og anvendelse derav
NO20040702L (no) Kombinerte preparater som inneholder 1,4-benzotiepin-1,1-dioksidderivater og andre aktive substanser og anvendelsen derav
ATE291914T1 (de) Zolmitriptanhaltige arzneizusammensetzungen
NO20011217D0 (no) Doseringsform omfattende væskeformulering
DE60019334D1 (de) Antivirale arznei
ATE301999T1 (de) Racecadotril enthaltende trockene pulverformulierung
NO20040055L (no) Sarbandasje
DK1330258T3 (da) Kahalalid F-formulering
PL402550A1 (pl) Dopochwowe kompozycje farmaceutyczne oraz zastosowanie zródla nadtlenku i bioadhezyjnego nosnika
DE60024476D1 (de) Pedikulizide und veterinärmedizinische zusammensetzungen
BR0213278B1 (pt) composição vedante e seu uso.
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
ATE297760T1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
SE0001916D0 (sv) Novel formulation
BR0108846A (pt) Formulação de oxazolidinona em comprimido

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1409034

Country of ref document: EP